122 related articles for article (PubMed ID: 1153405)
1. Serum prolactin levels of rats under continuous estrogen stimulation and 2 Br-alpha-ergocryptine (CB-154) injection.
Gala RR; Boss RS
Proc Soc Exp Biol Med; 1975 Jun; 149(2):330-2. PubMed ID: 1153405
[TBL] [Abstract][Full Text] [Related]
2. The influence of 2 br-alpha-ergocryptine (CB-154) and apomorphine on induced prolactin secretion in the crab eating monkey (Macaca fascicularis).
Gala RR; Jaques S
Endocr Res Commun; 1975; 2(1):95-108. PubMed ID: 807469
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
Sinha YN; Salocks CB; VanderLaan WP
Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
[TBL] [Abstract][Full Text] [Related]
4. The effects of methoxyflurane and ether alone or in combination with apomorphine 2 Br-alpha-ergocryptine (CB-154) on prolactin release in ovariectomized, estrogen-treated rats.
Subramanian MG; Lawson DM; Gala RR
Life Sci; 1976 Feb; 18(3):305-10. PubMed ID: 946549
[No Abstract] [Full Text] [Related]
5. Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells.
Lloyd HM; Meares JD; Jacobi J
Nature; 1975 Jun; 255(5508):497-8. PubMed ID: 1138203
[No Abstract] [Full Text] [Related]
6. Effect of prolactin inhibitory agents on the ectopic anterior pituitary and the mammary gland in rats.
Gräf KJ; Horowski R; Etreby MF
Acta Endocrinol (Copenh); 1977 Jun; 85(2):267-78. PubMed ID: 325978
[TBL] [Abstract][Full Text] [Related]
7. The influence of adrenalectomy and of corticosterone administration on the ether-induced increase in plasma prolactin in ovariectomized estrogen-treated rats.
Subramanian MG; Gala RR
Proc Soc Exp Biol Med; 1978 Mar; 157(3):415-7. PubMed ID: 634981
[No Abstract] [Full Text] [Related]
8. Treatment of fibrocystic disease of the breast with a prolactin inhibitor: 2-Br-alpha-ergocryptine (CB-154).
Martin-Comin J; Pujol-Amat P; Cararach V; Davi E; Robyn C
Obstet Gynecol; 1976 Dec; 48(6):703-6. PubMed ID: 1036613
[TBL] [Abstract][Full Text] [Related]
9. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
Seki K; Seki M; Okumura T
Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
[TBL] [Abstract][Full Text] [Related]
10. Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.
Pontiroli AE; Castegnaro E; Vettaro MP; Viberti GC; Pozza G
Acta Endocrinol (Copenh); 1977 Jan; 84(1):36-44. PubMed ID: 318788
[No Abstract] [Full Text] [Related]
11. 2-bromo-alpha-ergocryptine mesylate (CB-154) inhibits prolactin and luteinizing hormone secretion in the prepubertal female rat.
Shaban MA; Terranova PF
Biol Reprod; 1986 Jun; 34(5):788-95. PubMed ID: 3089338
[TBL] [Abstract][Full Text] [Related]
12. Interaction of estrogen and prolactin in spontaneous mammary tumorigenesis of the mouse.
Welsch CW
J Toxicol Environ Health Suppl; 1976; 1():161-75. PubMed ID: 1036505
[TBL] [Abstract][Full Text] [Related]
13. Changes of cell morphology and prolactin secretion induced by 2-Br-alpha-ergocryptine, estradiol, and thyrotropin-releasing hormone in rat anterior pituitary cells in culture.
Antakly T; Pelletier G; Zeytinoglu F; Labrie F
J Cell Biol; 1980 Aug; 86(2):377-87. PubMed ID: 6772648
[TBL] [Abstract][Full Text] [Related]
14. The influence of long term estrogen treatment on plasma prolactin levels induced by ether anesthesia in ovariectomized rats.
Goodman GT; Lawson DM
Experientia; 1977 Apr; 33(4):536-7. PubMed ID: 862764
[TBL] [Abstract][Full Text] [Related]
15. Alteration of the mammotroph Golgi complex by the dopamine agonist 2 Br-alpha-ergocryptine (CB-154) in ovariectomized estrogen primed rats.
Poole MC; Easley CS; Hodson CA
Anat Rec; 1991 Nov; 231(3):339-46. PubMed ID: 1763815
[TBL] [Abstract][Full Text] [Related]
16. Metaclopramide and prolactin secretion in man: effects of pretreatment with L-dopa and 2-bromo-alpha-ergocryptine (CB-154).
Delitala G; Masala A; Alagna S; Devilla L
IRCS J Med Sci; 1975 Jun; 3(6):274. PubMed ID: 1165172
[No Abstract] [Full Text] [Related]
17. Effect of 2-bromo-alpha-ergocryptine (CB 154) on plasma prolactin, LH and testosterone levels, accessory reproductive glands and spermatogenesis in lambs during puberty.
Ravault JP; Courot M; Garnier D; Pelletier J; Terqui M
Biol Reprod; 1977 Sep; 17(2):192-7. PubMed ID: 578119
[TBL] [Abstract][Full Text] [Related]
18. Effect of 2-bromo-alpha-ergocryptine (CB-154) on estrogen induced growth of the rat prostate.
Resnick MI; Grayhack JT
Invest Urol; 1978 Mar; 15(5):392-4. PubMed ID: 565341
[TBL] [Abstract][Full Text] [Related]
19. Effect of bromocriptine (CB-154) on oestrogen-induced prolactin release.
D'Agata R; Scapagnini U
Acta Endocrinol (Copenh); 1979 Feb; 90(2):193-7. PubMed ID: 419914
[TBL] [Abstract][Full Text] [Related]
20. Indirect evidences of prolactin involvement in precocious puberty induced by hypothalamic lesions in female rats.
Alvarez EO; Hancke JL; Advis JP
Acta Endocrinol (Copenh); 1977 May; 85(1):11-7. PubMed ID: 577071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
